Medpace Holdings, Inc. Accrued Liabilities, Current
Medpace Holdings, Inc. (MEDP) had Accrued Liabilities, Current of $451.08 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-07-23
- 2026-06-30: Accrued Liabilities, Current $451.08M.
- 2026-03-31: Accrued Liabilities, Current $406.06M.
- 2025-12-31: Accrued Liabilities, Current $408.38M.
- 2025-09-30: Accrued Liabilities, Current $368.75M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $451.08M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $406.06M 10-Q · filed 2026-04-23 |
| 2025-12-31 | $408.38M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $368.75M 10-Q · filed 2025-10-23 |
| 2025-06-30 | $323.50M 10-Q · filed 2025-07-22 |
| 2025-03-31 | $286.10M 10-Q · filed 2025-04-22 |
| 2024-12-31 | $307.81M 10-K · filed 2026-02-10 |
| 2024-09-30 | $306.87M 10-Q · filed 2024-10-22 |
| 2024-06-30 | $292.66M 10-Q · filed 2024-07-23 |
| 2024-03-31 | $270.93M 10-Q · filed 2024-04-23 |
| 2023-12-31 | $292.96M 10-K · filed 2025-02-11 |
| 2023-09-30 | $264.79M 10-Q · filed 2023-10-24 |
| 2023-06-30 | $231.93M 10-Q · filed 2023-07-25 |
| 2023-03-31 | $201.20M 10-Q · filed 2023-04-25 |
| 2022-12-31 | $210.13M 10-K · filed 2024-02-13 |
| 2022-09-30 | $204.12M 10-Q · filed 2022-10-25 |
| 2022-06-30 | $173.19M 10-Q · filed 2022-07-26 |
| 2022-03-31 | $155.02M 10-Q · filed 2022-04-26 |
| 2021-12-31 | $159.29M 10-K · filed 2023-02-14 |
| 2021-09-30 | $158.21M 10-Q · filed 2021-10-26 |
| 2021-06-30 | $145.85M 10-Q · filed 2021-07-27 |
| 2021-03-31 | $123.61M 10-Q · filed 2021-04-27 |
| 2020-12-31 | $134.37M 10-K · filed 2022-02-15 |
| 2020-09-30 | $117.00M 10-Q · filed 2020-10-27 |
| 2020-06-30 | $102.95M 10-Q · filed 2020-07-28 |
| 2020-03-31 | $107.00M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $109.25M 10-K · filed 2021-02-16 |
| 2019-09-30 | $102.53M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $93.60M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $82.25M 10-Q · filed 2019-04-30 |
| 2018-12-31 | $87.49M 10-K · filed 2020-02-25 |
| 2018-09-30 | $80.33M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $72.92M 10-Q · filed 2018-07-31 |
| 2018-03-31 | $63.58M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $23.67M 10-K · filed 2019-02-26 |
| 2017-09-30 | $20.09M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $16.39M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $14.08M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $24.42M 10-K · filed 2018-02-27 |
| 2016-09-30 | $21.41M 10-Q · filed 2016-11-03 |
| 2015-12-31 | $20.11M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |